Your browser doesn't support javascript.
loading
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Blanc-Durand, Félix; Yaniz-Galende, Elisa; Llop-Guevara, Alba; Genestie, Catherine; Serra, Violeta; Herencia-Ropero, Andrea; Klein, Christophe; Berton, Dominique; Lortholary, Alain; Dohollou, Nadine; Desauw, Christophe; Fabbro, Michel; Malaurie, Emmanuelle; Bonichon-Lamaichhane, Nathalie; Dubot, Coraline; Kurtz, Jean Emmanuel; de Rauglaudre, Gaëtan; Raban, Nadia; Chevalier-Place, Annick; Ferron, Gwenael; Kaminsky, Marie-Christine; Kramer, Claire; Rouleau, Etienne; Leary, Alexandra.
Afiliación
  • Blanc-Durand F; Medical Oncology, Gynecology Unit, Gustave Roussy Institute, Villejuif, France.
  • Yaniz-Galende E; INSERM UMR981, Gustave Roussy Institute, Villejuif, France.
  • Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Genestie C; Pathology Department, Gustave Roussy Institute, Villejuif, France.
  • Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Herencia-Ropero A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Klein C; Center of Cellular Imaging and Cytometry, INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
  • Berton D; Medical Oncology, GINECO & Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Lortholary A; Medical Oncology, GINECO-Hôpital Privé du Confluent, Nantes, France.
  • Dohollou N; Medical Oncology, Polyclinique Bordeaux Nord Aquitain, Bordeaux, France.
  • Desauw C; Medical Oncology, Centre Hospitalier Universitaire, Lille, France.
  • Fabbro M; Medical Oncology, ICM Val d'Aurelle, Montpellier, France.
  • Malaurie E; Medical Oncology, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Bonichon-Lamaichhane N; Medical Oncology, Clinique Tivoli-Ducos, Bordeaux, France.
  • Dubot C; Medical Oncology, GINECO and Institut Curie - Hôpital René Huguenin, Saint-Cloud, France.
  • Kurtz JE; Medical Oncology, CHU Stasbourg, Strasbourg, France.
  • de Rauglaudre G; Medical Oncology, GINECO and Institut Sainte- Catherine, Avignon, France.
  • Raban N; Medical Oncology, GINECO and CHU La Milétrie, Poitiers, France.
  • Chevalier-Place A; Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Ferron G; Medical Oncology, GINECO and Institut Claudius Regaud, Toulouse, France.
  • Kaminsky MC; Medical Oncology, GINECO and Institut de Cancérologie de Lorraine, Vandoeuvre-Les-, Nancy, France.
  • Kramer C; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  • Rouleau E; Cancer Genetics Laboratory, Gustave Roussy Institute, Villejuif, France.
  • Leary A; Medical Oncology, Gynecology Unit, Gustave Roussy Institute, Villejuif, France; INSERM UMR981, Gustave Roussy Institute, Villejuif, France. Electronic address: alexandra.leary@gustaveroussy.fr.
Gynecol Oncol ; 175: 194, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37271667
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia